About Us
Neolacta Lifesciences develops lifesaving products derived from human milk. Our human milk based nutritional products are extensively used for babies who have difficulty in accessing mothers’ own milk.
We are the only company in India and Asia to have developed 100% human milk products which address the needs of neonatal nutrition and thus play a critical role in supporting the “intact survival” of the premature babies.
Pasteurized human donor milk is specially used in neonatal intensive care units (NICU) benefiting a lot of premature, low birth weight babies. Its also helps babies whose mothers have difficulty in feeding their own babies due to medical reasons and babies born through surrogacy or IVF.
Our products, which are highly recommended by neonatologists and pediatricians, are available in leading hospitals across India.
Till date, more than ten thousand premature babies have benefited from our products, without any complications.
We follow very stringent processes and comply with the key statutory requirements of the following bodies, towards the collection, processing and distribution of our products.
• Indian Academy of Pediatrics (IAP)
• Human Milk Banking Association of North America (HMBANA)
• American Academy of Pediatrics (AAP)
Mothers who have excess breast milk can also help save the life of a fragile babies by donating their surplus breast milk, by becoming a donor mother through our donor program.
The benefits of pasteurized human milk are striking when compared to infant formula.
Human milk components in fresh mother’s milk after freezing and pasteurization Vs. formula and special formula
| Components | Expressed breast milk (EBM) | After freezing and pasteurization | Formula | Special Formula | Functions |
| IgA and SlgA | 100 | 67-70 | 0 | 0 | Infant’s do not produce SlgA until 6-9 months; active against Polio, Coxsackievirus, Herpes, CMV, RSV, Rubella, and Rotavirus. |
| IgM | 100 | 100 | 0 | 0 | Active against CMV, RSV, and Rubella. |
| IgG | 100 | 66-70 | 0 | 0 | Active against CMV, RSV, and Rubella. |
| Lactoferrin | 100 | 27-43 | 0 | 0 | The protein that binds iron required by many bacteria and thus slows bacterial growth. |
| Lysozyme | 100 | 75 | 0 | 0 | Enzymes that break bacterial cell walls, destroying them. |
| Lipases | 0 | 0 | 0 | 0 | Protect against “envelop viruses”. |
| Monoglycerides | 100 | 100 | 0 | 0 | Disrupts membrane coating of many viruses and protozoans destroying them. |
| Free fatty acids | 100 | 100 | Added to some formulas | – | Disrupts membrane coating of many viruses and protozoans destroying them. |
| Linoleic acid | 100 | 100 | Added to some formulas | – | Essential fatty acid; the metabolic precursor for prostaglandins and leukotrienes. |
| Alpha-linolenic acid | 100 | 100 | Added to some formulas | – | Essential fatty acid; metabolic precursor for docosahexaenoic acid; important for eye and brain development. |
| Bifidus factor | 100 | 70-100 | – | – | Promotes growth of Lactobacillus bifidus, a harmless bacterium to prevent the growth of harmful bacteria in the gut. |
| Oligosacc | 100 | 100 | – | – | Binds harmful bacteria. |
| Vitamin A | 100 | 100 | – | – | Protection against disease; gut mucosa sensitive to vitamin A. |
The table is adapted from Tully DB, Jones F and Tully MR. Donor milk; What’s in it and what’s not. J Hum Lact. 2001;17(2):152-155.
